Microbicide Trials Network

HPTN 059


The trial, now complete, assessed the safety and acceptability of the antiretroviral-based candidate microbicide tenofovir topical gel used either daily or before each act of sex in 200 HIV-negative women at three sites in India and the United States.

 

See

Trial finds tenofovir gel safe for daily use and most women adhered to study regimens

25-February-2008  

  

HPTN 059 Backgrounder

18-February-2008  

  

HPTN 059 Q&A

18-February-2008  

 

See Also

HPTN 059 Protocol